Reduction of serum cholesterol in postmenopausal women with previous myocardial infarction and cholesterol malabsorption induced by dietary sitostanol ester margarine: Women and dietary sitostanol

Circulation

Volumn 96, Issue 12, 1997, Pages 4226-4231

  Gylling, Helena ^b   Radhakrishnan, Rajaratnam ^b   Miettinen, Tatu A ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b NONE

Author keywords

Cholesterol; Diet; Myocardial infarction; Women

Indexed keywords

CHOLESTEROL; MARGARINE; SIMVASTATIN; SITOSTANOL;

ADULT; ARTICLE; BRASSICA; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; DIET THERAPY; DIETARY INTAKE; FAT INTAKE; FEMALE; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; MALABSORPTION; POSTMENOPAUSE; PRIORITY JOURNAL;

EID: 0031470415     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.12.4226     Document Type: Article

References (31)

1. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, Macfarlane PW, McKillop JH, Packard CJ, for the West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med. 1995;333:1301-1307.
2. The Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383-1389.
3. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, Brown L, Warnica JW, Arnold JMO, Wun CC, Davis BR, Braunwald E, for the Cholesterol and Recurrent Events Trial Investigators. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med. 1996;335:1001-1009.
4. Gylling H, Miettinen TA. The effect of cholesterol absorption inhibition on low density lipoprotein cholesterol level. Atherosclerosis. 1995;117:305-308.
5. Miettinen TA, Puska P, Gylling H, Vanhanen H, Vartiainen E. Serum cholesterol lowering by sitostanol ester margarine in a mildly hypercholesterolemic random population. N Engl J Med. 1995;333:1308-1312.
6. Miettinen TA. Gas-liquid Chromatographic determination of fecal neutral sterols using a capillary column. Clin Chim Acta. 1982;124:245-248.
7. Miettinen TA, Koivisto P. Non-cholesterol sterols and bile acid production in hypercholesterolemic patients with ileal by-pass. In Paumgartner G, Stiehl A, Gerok W, eds. Bile Acids and Cholesterol in Health and Disease. Lancaster/Philadelphia: MTP; 1983:183-187.
8. Miettinen TA. Cholesterol metabolism during ketoconazole treatment in man. J Lipid Res. 1988;29:43-51.
9. Miettinen TA. Detection of changes in human cholesterol metabolism. Ann Clin Res. 1970;2:1-21.
10. Miettinen TA. Serum methyl sterols and their distribution between major lipoprotein fractions in different clinical conditions. Ann Clin Res. 1971;3:264-271.
11. Färkkilä MA, Tilvis RS, Miettinen TA. Raised plasma cholesterol precursors in patients with gut resections. Gut. 1988;29:188-195.
12. Björkhem I, Miettinen TA, Reihner E, Ewerth S, Angelin B, Einarsson K. Correlation between serum levels of some cholesterol precursors and activity of HMG-CoA reductase in human liver. J Lipid Res. 1987;28:1137-1143.
13. Kempen HJM, Glatz JFC, Leuven JAG, Voort van der HA, Katan MB. Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans. J Lipid Res. 1988;29:1149-1155.
14. Miettinen TA, Tilvis RS, Kesäniemi YA. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population. Am J Epidemiol. 1990;131:20-31.
15. Tilvis RS, Miettinen TA. Serum plant sterols and their relation to cholesterol absorption. Am J Clin Nutr. 1986;43:92-97.
16. Crouse JR, Grundy SM. Evaluation of a continuous isotope feeding method for measurement of cholesterol absorption in man. J Lipid Res. 1978;19:967-971.
17. 3) when used as an index substance. Science. 1952;116:634-635.
18. Miettinen TA, Ahrens EH Jr, Grundy SM. Quantitative isolation and gas-liquid Chromatographic analysis of total dietary and fecal neutral steroids. J Lipid Res. 1965;6:411-424.
19. Grundy SM, Ahrens EH Jr, Miettinen TA. Quantitative isolation and gas-liquid Chromatographic analysis of total fecal bile acids. J Lipid Res. 1965;6:397-410.
20. Knuts LR, Rastas M, Haapala P. Micro-Nutrica. Version 1.0. Helsinki: Kansaneläkelaitos (National Pensions Institute); 1991.
21. Miettinen TA, Vanhanen H. Serum concentration and metabolism of cholesterol during rapeseed oil and squalene feeding. Am J Clin Nutr. 1994;59:356-363.
22. Expert panel on detection evaluation and treatment of high blood cholesterol in adults: summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection evaluation and treatment of high blood cholesterol in adults (Adult treatment panel 2). JAMA. 1993;269:3015-3023.
23. Vanhanen HT, Blomqvist S, Ehnholm C, Hyvönen M, Jauhiainen M, Torstila I, Miettinen TA. Serum cholesterol, cholesterol precursors, and plant sterols in hypercholesterolemic subjects with different apoE phenotypes during dietary sitostanol ester treatment. J Lipid Res. 1993;34:1535-1544.
24. Gylling H, Miettinen TA. Serum cholesterol and cholesterol and lipoprotein metabolism in hypercholesterolaemic NIDDM patients before and during sitostanol ester-margarine treatment. Diabetologia. 1994;37:773-780.
25. The Lovastatin Study Group III. A multicenter comparison of lovastatin and cholestyramine therapy for severe primary hypercholesterolemia. JAMA. 1988;260:359-366.
26. Pravastatin Multicenter Study Group II. Comparative efficacy and safety of pravastatin and cholestyramine alone and combined in patients with hypercholesterolemia. Arch Int Med. 1993;153:1321-1329.
27. Mattson FH, Grundy SM, Crouse JR. Optimizing the effect of plant sterols on cholesterol absorption in man. Am J Clin Nutr. 1982;35:697-700.
28. Denke MA. Lack of efficacy of low-dose sitostanol therapy as an adjunct to a cholesterol-lowering diet in men with moderate hypercholesterolemia. Am J Clin Nutr. 1995;61:392-396.
29. Miettinen TA, Kesäniemi YA. Cholesterol absorption: regulation of cholesterol synthesis und elimination und within-population variations of serum cholesterol levels. Am J Clin Nutr. 1989;49:629-635.
30. Miettinen TA, Strandberg T, Vanhanen H, Gylling H, for the 4S Group. Non-cholesterol serum sterols in Scandinavian Simvastatin Survival Study. In: Gotto AM Jr, Paoletti R, Smith LC, Catapano AL, Jackson AS, eds. Drugs Affecting Lipid Metabolism. Dordrecht: Kluwer Academic Publishers: Medical Science Symposium series, Vol 10. 1996:473-476.
31. Gylling H, Miettinen TA. The effects of inhibiting cholesterol synthesis and absorption on cholesterol and lipoprotein metabolism in hypercholesterolemic non-insulin dependent diabetic men. J Lipid Res. 1996;37:1776-1785.